149 related articles for article (PubMed ID: 34793864)
1. Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.
Wennerberg J; Gebre-Medhin M; Nilsson P; Brun E; Kjellén E; Carlwig K; Reizenstein J; Kristiansson S; Söderkvist K; Wahlgren M; Zackrisson B;
Radiother Oncol; 2022 Jan; 166():26-32. PubMed ID: 34793864
[TBL] [Abstract][Full Text] [Related]
2. Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study.
Zackrisson B; Nilsson P; Kjellén E; Johansson KA; Modig H; Brun E; Nyman J; Friesland S; Reizenstein J; Sjödin H; Ekberg L; Lödén B; Mercke C; Fernberg JO; Franzén L; Ask A; Persson E; Wickart-Johansson G; Lewin F; Wittgren L; Björ O; Björk-Eriksson T
Radiother Oncol; 2011 Jul; 100(1):41-8. PubMed ID: 21295880
[TBL] [Abstract][Full Text] [Related]
3. Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
Zackrisson B; Kjellén E; Söderström K; Brun E; Nyman J; Friesland S; Reizenstein J; Sjödin H; Ekberg L; Lödén B; Franzén L; Ask A; Wickart-Johansson G; Lewin F; Björk-Eriksson T; Lundin E; Dalianis T; Wennerberg J; Johansson KA; Nilsson P
Radiother Oncol; 2015 Oct; 117(1):99-105. PubMed ID: 26427805
[TBL] [Abstract][Full Text] [Related]
4. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
[TBL] [Abstract][Full Text] [Related]
5. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
Laskar SG; Chaukar D; Deshpande M; Chatterjee A; Sinha S; Chakraborty S; Agarwal JP; Gupta T; Budrukkar A; Murthy V; Pai P; Chaturvedi P; Pantvaidya G; Deshmukh A; Nair D; Nair S; Prabhash K; Swain M; Kumar A; Noronha V; Patil V; Joshi A; DCruz A
Eur J Cancer; 2023 Mar; 181():179-187. PubMed ID: 36669426
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of purely accelerated six fractions per week radiotherapy in postoperative oral cavity squamous cell carcinoma.
Rath S; Khurana R; Sapru S; Rastogi M; Gandhi AK; Hadi R; Sahni K; Mishra SP; Srivastava AK; Syedkather F
Asia Pac J Clin Oncol; 2020 Feb; 16(1):14-22. PubMed ID: 31793206
[TBL] [Abstract][Full Text] [Related]
7. Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
Nyqvist J; Fransson P; Laurell G; Hammerlid E; Kjellén E; Franzén L; Söderström K; Wickart-Johansson G; Friesland S; Sjödin H; Brun E; Ask A; Nilsson P; Ekberg L; Björk-Eriksson T; Nyman J; Lödén B; Lewin F; Reizenstein J; Lundin E; Zackrisson B
Radiother Oncol; 2016 Feb; 118(2):335-41. PubMed ID: 26777124
[TBL] [Abstract][Full Text] [Related]
8. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study.
Antognoni P; Bignardi M; Cazzaniga LF; Poli AM; Richetti A; Bossi A; Rampello G; Barbera F; Soatti C; Bardelli D; Giordano M; Danova M
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1137-45. PubMed ID: 8985036
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
10. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
[TBL] [Abstract][Full Text] [Related]
11. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers].
Horiot JC
Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410
[TBL] [Abstract][Full Text] [Related]
12. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
[TBL] [Abstract][Full Text] [Related]
13. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
[TBL] [Abstract][Full Text] [Related]
15. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma.
Herman MP; Dagan R; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Mendenhall WM
Laryngoscope; 2015 Mar; 125(3):630-5. PubMed ID: 25376116
[TBL] [Abstract][Full Text] [Related]
17. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck.
Trotti A; Klotch D; Endicott J; Ridley M; Greenberg H
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):13-21. PubMed ID: 8482619
[TBL] [Abstract][Full Text] [Related]
18. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
[TBL] [Abstract][Full Text] [Related]
19. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer.
Suwiński R; Bańkowska-Woźniak M; Majewski W; Idasiak A; Maciejewski A; Ziółkowska E; Windorbska W; Składowski K; Miszczyk L; Maciejewski B
Radiother Oncol; 2008 May; 87(2):155-63. PubMed ID: 18342964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
